Sarepta Therapeutics | Marktkapitalisierung



Market Capitalization Veränderung Datum
Acadia Pharmaceuticals USD 2.46B 312M 2025-04
Agios Pharmaceuticals USD 1.57B 303M 2025-04
Alnylam Pharmaceuticals USD 29.63B 5.49B 2025-04
Amgen USD 155.38B 15.41B 2025-04
Biogen USD 17.08B 5.2B 2025-04
BioMarin Pharmaceutical USD 11.34B 1.19B 2025-04
Daiichi Sankyo JPY 6.64T 64.31B 2025-04
Eli Lilly USD 706.59B 26.28B 2025-04
Gilead Sciences USD 128.49B 11.2B 2025-04
Incyte USD 13.05B 253M 2025-04
Insmed USD 10.42B 1.96B 2025-04
Ionis Pharmaceuticals USD 4.15B 1.37B 2025-04
Moderna USD 9.83B 6.17B 2025-04
Neurocrine Biosciences USD 9.87B 3.95B 2025-04
Pfizer USD 126.33B 24.01B 2025-04
PTC Therapeutics USD 3.43B 77M 2025-04
Regeneron Pharmaceuticals USD 60.81B 8.53B 2025-04
Sanofi EUR 115.8B 10.04B 2025-04
Sarepta Therapeutics USD 5.03B 6.76B 2025-04
Tectonic Therapeutic USD 262M 69M 2025-04
Ultragenyx Pharmaceutical USD 2.86B 1.03B 2025-04
Vertex Pharmaceuticals USD 127.19B 23.74B 2025-04



Sarepta Therapeutics Marktkapitalisierung - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.